Aspira Women's Health Inc. Reports Board and Officer Changes
Ticker: AWHL · Form: 8-K · Filed: Jan 31, 2025 · CIK: 926617
Sentiment: neutral
Topics: management-change, board-of-directors, officer-departure
Related Tickers: AWH
TL;DR
Aspira Women's Health (AWH) board shake-up: new directors elected, some officers out.
AI Summary
Aspira Women's Health Inc. announced on January 28, 2025, a change in its board of directors. Specifically, the company reported the departure of certain officers and the election of new directors, alongside updates to compensatory arrangements for its officers.
Why It Matters
Changes in board composition and officer roles can signal shifts in company strategy, leadership, and governance, potentially impacting future performance and investor confidence.
Risk Assessment
Risk Level: medium — Board and officer changes can indicate internal instability or strategic realignments, which carry inherent risks.
Key Players & Entities
- Aspira Women's Health Inc. (company) — Registrant
- January 28, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
FAQ
Who are the specific officers that departed from Aspira Women's Health Inc.?
The filing indicates the departure of certain officers but does not name them specifically in the provided text.
Who are the newly elected directors to the Aspira Women's Health Inc. board?
The filing states that directors were elected but does not provide their names in the provided text.
What specific changes were made to the compensatory arrangements of the officers?
The filing mentions updates to compensatory arrangements but does not detail the specifics of these changes in the provided text.
What is the effective date of these board and officer changes?
The earliest event reported is January 28, 2025, which is the date of the changes.
Does this 8-K filing disclose any financial performance metrics?
No, this 8-K filing focuses on changes in directors and officers and compensatory arrangements, not financial performance.
Filing Stats: 740 words · 3 min read · ~2 pages · Grade level 11.8 · Accepted 2025-01-31 06:15:25
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share AWH The Nasdaq Stock Mark
Filing Documents
- form8-k.htm (8-K) — 39KB
- 0001493152-25-004329.txt ( ) — 210KB
- awh-20250128.xsd (EX-101.SCH) — 3KB
- awh-20250128_lab.xml (EX-101.LAB) — 33KB
- awh-20250128_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Aspira Women's Health Inc. Date: January 31, 2025 By: /s/ Michael Buhle Michael Buhle, Chief Executive Officer -3-